Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-11-018934)

Filing Details

Accession Number:: 0001140361-11-018934
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-03-28 16:40:38
Reporting Period:: 2011-03-27

Filing Date:: 2011-03-28
Accepted Time:: 2011-03-28 16:40:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
69499	Mylan Inc.	MYL	Pharmaceutical Preparations (2834)	251211621

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1388111	Rajiv Malik	1500 Corporate Drive Canonsburg PA 15317	Evp & Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-03-27	5,660	$0.00	145,844	No	4	M	Direct
Common Stock	Disposition	2011-03-28	1,820	$22.30	144,024	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Acquisiton	2011-03-27	5,660	$0.00	5,660	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Represents shares sold to cover the tax liability associated with the vesting of a portion of the restricted stock units (RSUs) granted on March 27, 2009. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2011.
Each RSU represents the right to receive one share of Mylan Inc. common stock. The remainder of this award will vest on March 27, 2012.